• A Dubai ambulance worker is vaccinated with the Pfizer-BioNtech vaccine in Dubai.
    A Dubai ambulance worker is vaccinated with the Pfizer-BioNtech vaccine in Dubai.
  • An older resident receives her first shot at Zabeel Health Centre on December 27, 2020.
    An older resident receives her first shot at Zabeel Health Centre on December 27, 2020.
  • The vaccine is expected to be rolled out to all age groups once people in the essential categories have been vaccinated.
    The vaccine is expected to be rolled out to all age groups once people in the essential categories have been vaccinated.
  • A nurse holds a dose of the Pfizer-BioNTech vaccine, which was approved for use by Dubai's emergency and crisis authority and the federal Ministry of Health.
    A nurse holds a dose of the Pfizer-BioNTech vaccine, which was approved for use by Dubai's emergency and crisis authority and the federal Ministry of Health.
  • An employee from Roads and Transport Authority receives a dose of the Pfizer-BioNTech vaccine in Dubai.
    An employee from Roads and Transport Authority receives a dose of the Pfizer-BioNTech vaccine in Dubai.
  • A woman receives a dose of the Pfizer-BioNTech vaccine at Zabeel Health Centre in Dubai on 27 December, 2020.
    A woman receives a dose of the Pfizer-BioNTech vaccine at Zabeel Health Centre in Dubai on 27 December, 2020.
  • The city has six vaccine centres where the Pfizer-BioNTech shot is available.
    The city has six vaccine centres where the Pfizer-BioNTech shot is available.
  • A man waits to receive the first of two doses at Zabeel Health Centre in Dubai on 27 December, 2020.
    A man waits to receive the first of two doses at Zabeel Health Centre in Dubai on 27 December, 2020.
  • A nurse opens a freezer at Barsha Health Centre. The Pfizer-BioNTech vaccine must be kept at minus 70C when transported.
    A nurse opens a freezer at Barsha Health Centre. The Pfizer-BioNTech vaccine must be kept at minus 70C when transported.
  • A nurse opens a freezer at Barsha Health Centre. The Pfizer-BioNTech vaccine must be kept at minus 70C when transported.
    A nurse opens a freezer at Barsha Health Centre. The Pfizer-BioNTech vaccine must be kept at minus 70C when transported.
  • A vial of the vaccine is seen at Barsha Health Centre. AFP
    A vial of the vaccine is seen at Barsha Health Centre. AFP
  • A nurse prepares a dose of the Pfizer-BioNTech vaccine at al-Barsha Health Centre in Dubai. AFP
    A nurse prepares a dose of the Pfizer-BioNTech vaccine at al-Barsha Health Centre in Dubai. AFP

DHA hospitals in Dubai suspend non-urgent dental treatments as Covid-19 cases increase


Gillian Duncan
  • English
  • Arabic

Dubai Health Authority hospitals and clinics suspended non-urgent dental treatments as Covid-19 cases rise across the country, the emirate's health authority said.

Urgent dental procedures are being carried out at select facilities.

Al Mizhar Health Centre, Nad Al Hamar Health Centre, Al Barsha Health Centre, Al Safa Health Centre, Al Mamzar Health Centre (for children only), Rashid Hospital and Hatta Hospital will accept patients from Sunday to Thursday between 7.30am and 9.30pm.

The procedures are being done with strict preventative measures in place. Staff are being asked to wear “special masks, face shields, gloves and medical gowns that cover the entire body" the DHA said.

“Other measures implemented at the facilities include ensuring physical distancing between customers and comprehensive sterilisation after each patient.

“This is a precautionary measure to protect patients and healthcare personnel from Covid-19 and prevent its spread.”

Last week, hospitals in Dubai were instructed to cancel all non-essential surgery for a month.

The ban will last until February 19, the DHA said.

The emirate later prohibited all live entertainment in hotels and restaurants and limited the number of diners permitted to sit together at one table.

On Tuesday, the UAE announced 3,601 new cases, extending its streak of record infections to 15 days.

The latest daily high brought the country’s tally since the pandemic began to 285,147.

A further 3,890 patients received the all-clear as the recovery total rose to 259,194.

Seven patients died, taking the country’s toll to 805.

Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.

Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.

Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.

Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.

“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.

Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.

From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.

Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.

BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.

Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.

Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.

“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.

Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.

“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.

“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”

The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”